 |
|
Status of Usage of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration.
Songhee Cho, Sang Jin Shin, Jae Kyung Suh, Hajin Tchoe, Min Joo Kang, Jangmi Yang, Donghyun Jee
J Korean Ophthalmol Soc. 2019;60(8):758-764. Published online 2019 Aug 15 DOI: https://doi.org/10.3341/jkos.2019.60.8.758
|
|
Citations to this article as recorded by
 Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration
Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2021; 62(8): 1076. CrossRef Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration
Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2021; 62(9): 1218. CrossRef Short-term Efficacy of Brolucizumab Injection for Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept
Jae Hui Kim
Journal of Retina.2021; 6(2): 145. CrossRef Evaluation of the Safety of Bilateral Same-day Intravitreal Aflibercept Injections
Jayoung Ahn, Zee Yoon Byun, Kyu Hwan Jang, Joon Hong Sohn, Daniel Duck-Jin Hwang
Journal of Retina.2020; 5(2): 94. CrossRef
|